CAS: 1163719-56-9
Ref: IN-DA0096DJ
| 5mg | 129.00 € | ||
| 10mg | 180.00 € | ||
| 25mg | 503.00 € | ||
| 50mg | 627.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
CCT196969
CAS:1163719-56-9
CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, …
Formula:
C27H24FN7O3
Purity:
98.58% - 99.65%
Color and Shape:
Solid
Molecular weight:
513.52
Ref: TM-T4133
| 2mg | 35.00 € | ||
| 5mg | 52.00 € | ||
| 10mg | 83.00 € | ||
| 25mg | 157.00 € | ||
| 50mg | 245.00 € | ||
| 100mg | 398.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 54-BISN0303
| 1mg | 84.00 € | ||
| 5mg | 134.00 € | ||
| 10mg | 194.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
CCT196969
Controlled ProductCAS:1163719-56-9
Formula:
C27H24FN7O3
Color and Shape:
Neat
Molecular weight:
513.523
Ref: TR-C227940
| 1g | 10,915.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Cct196969
CAS:1163719-56-9
CCT196969 is a drug candidate that has been shown to have anti-cancer properties. It has …
Formula:
C27H24FN7O3
Purity:
Min. 95%
Molecular weight:
513.52 g/mol
Ref: 3D-NWB71956
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
